News and Opinions

U.S. Senate Clears NCBI Re-Authorization

U.S. Senate Clears NCBI Re-Authorization

Legislation is headed to President's desk for signature May 19, 2021 - The U.S. Senate has unanimously approved re-authorization of the National Cord Blood Inventory (NCBI) at up to $23 million annually through Fiscal Year 2026. The Senate sponsors of the bipartisan...

read more
The Regenerative Medicine Foundation is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.

Join Our Mailing List